Just like the Multi-Tool Pen, BRT does more than check the boxes. From pre-clinical support to in vitro and in vivo models, we deliver custom immunotoxicology solutions built to meet your study’s exact requirements.
Looking for quick reference materials? View our one-pager or learn about our service-specific capabilities below.
Integrated in vitro and in vivo approaches to evaluate immune safety and efficacy
Human cell-based assays to evaluate immune function and mechanistic responses
Rodent (mouse & rat) models to evaluate immune function, host resistance, and therapeutic efficacy
Dr. Florence Burleson | Co-Founder & EVP of BRT
With over 30 years of experience in immunotoxicology and immune safety, Dr. Burleson provides strategic scientific guidance across in vitro and in vivo study design. Her expertise spans host resistance, functional immune assays, and regulatory-focused immunotoxicology programs across pharmaceutical, government, and CRO environments.
